News Releases

News and information from The Leukemia & Lymphoma Society

LLS Invests $40.3 Million in New Research to Find Cures

View full multimedia release here   Rye Brook, NY – November 16, 2016 – The Leukemia & Lymphoma Society (LLS) today announced it has committed $40.3 million in new research investments to advance the most promising blood cancer science at leading academic and medical centers around the world, including Dana-Farber Cancer Institute in Boston; Weill Cornell Medicine and Memorial Sloan Kettering Cance...

MD Anderson Starts LLS-Funded Clinical Trial for Acute Myeloid Leukemia

Houston, TX- October 26, 2016 -- The University of Texas MD Anderson Cancer Center’s Institute for Applied Cancer Science (IACS) has initiated the first clinical study of a novel drug designed to starve cancer cells, IACS-10759. The study will enroll patients with acute myeloid leukemia (AML) and is supported by a $3.5 million investment from The Leukemia & Lymphoma Society (LLS) Therapy Acceleration Progr...

LLS Launches Groundbreaking Precision Medicine Approach to Treat AML

View full multimedia release here View media toolkit here As Announced Yesterday By Vice President Joe Biden, LLS to Lead First-Ever Blood Cancer Master Trial With Unprecedented Collaboration Between World-Renowned Researchers and Medical Centers, Biopharmaceutical Companies and a Leading Genomics Information Company to Advance Treatment for Cancer Affecting 20,000 Americans Annually   (Rye Brook, NY...

LLS Introduces Random Acts of Light

The Leukemia & Lymphoma Society® Introduces Random Acts of Light To Help Bring Moments of Light To Darkness of Cancer   Celebrities Surprise Their Biggest Fans Who Have Been Touched by Blood Cancers   Rye Brook, NY (October 6, 2016) – Today, The Leukemia & Lymphoma Society (LLS) is introducing Random Acts of Light, a new initiative to ...

Pages

Media Contact

Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: